Key result
C-peptide deposits in diabetic aortas and stimulates ~2.3-fold greater monocyte chemotaxis in vitro.
Case-Control
Answers are grounded in this paper and cite their sources.
OBJECTIVE: Increased levels of C-peptide, a cleavage product of proinsulin, circulate in patients with insulin resistance and early type 2 diabetes, a high-risk population for the development of a diffuse and extensive pattern of arteriosclerosis. This study tested the hypothesis that C-peptide might participate in atherogenesis in these patients. METHOD AND RESULTS: We demonstrate significantly higher intimal C-peptide deposition in thoracic aorta specimens from young diabetic subjects compared with matched nondiabetic controls as determined by immunohistochemical staining. C-peptide colocalized with monocytes/macrophages in the arterial intima of artery specimen from diabetic subjects. In vitro, C-peptide stimulated monocyte chemotaxis in a concentration-dependent manner with a maximal 2.3+/-0.4-fold increase at 1 nmol/L C-peptide. Pertussis toxin, wortmannin, and LY294002 inhibited C-peptide-induced monocyte chemotaxis, suggesting the involvement of pertussis toxin-sensitive G-proteins as well as a phosphoinositide 3-kinase (PI3K)-dependent mechanism. In addition, C-peptide treatment activated PI3K in human monocytes, as demonstrated by PI3K activity assays. CONCLUSIONS: C-peptide accumulated in the vessel wall in early atherogenesis in diabetic subjects and may promote monocyte migration into developing lesions. These data support the hypothesis that C-peptide may play an active role in atherogenesis in diabetic patients and suggest a new mechanism for accelerated arterial disease in diabetes.
No takes yet. Share an insight, caveat, or question.
Marx et al. (2004) conducted a case-control in Diabetes and early arteriosclerosis. C-peptide vs. Matched nondiabetic controls was evaluated on Intimal C-peptide deposition and in vitro monocyte chemotaxis (2.3±0.4-fold increase). C-peptide showed significantly higher intimal deposition in diabetic thoracic aortas and stimulated in vitro monocyte chemotaxis by up to 2.3±0.4-fold at 1 nmol/L.
Synapse has enriched 10 related papers. Consider them for comparative context: